Author:
Boccardo Francesco,Rubagotti Alessandra,Conti Giario,Potenzoni Domenico,Manganelli Antonio,Monaco Demetrio Del
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference13 articles.
1. Boccardo F, Rubagotti A, Garofalo L, Di Tonno P, Conti G, Bertaccini A, De Antoni P, Galassi P, Siragusa A, Durand F (2003) Tamoxifen is more effective than anastrozole in preventing gynecomastia and breast pain induced by bicalutamide monotherapy in prostate cancer patients. Proc Am Soc Clin Oncol 22:400 (abstract)
2. Buzdar AU (2003) Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors. Clin Cancer Res 9:468S–472S
3. Cockshott ID (2004) Bicalutamide: clinical pharmacokinetics and metabolism. Clin Pharmacokinet (in press)
4. Kaisary A, Klarskov P, McKillop D (1996) Absence of hepatic enzyme induction in prostate cancer patients receiving ‘Casodex’ (bicalutamide). Anticancer Drugs 7:54–59
5. McLeod DG, Iversen P (2000) Gynecomastia in patients with prostate cancer: a review of treatment options. Urology 56:713–720
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献